2024
Comparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women
Liu D, Li H, Li X, Rodriguez G, Pietz H, Fiel R, Konadu E, Singh V, Loo F, Rodgers W. Comparative Analysis of Viral Load and Cytokines during SARS-CoV-2 Infection between Pregnant and Non-Pregnant Women. International Journal Of Molecular Sciences 2024, 25: 7731. PMID: 39062978, PMCID: PMC11277191, DOI: 10.3390/ijms25147731.Peer-Reviewed Original ResearchConceptsNon-pregnant womenSARS-CoV-2 infectionResponse to SARS-CoV-2 infectionPregnant womenViral loadNeutralizing antibodiesImmune response to SARS-CoV-2 infectionAnalysis of viral loadSARS-CoV-2Retrospective cohort studyIgG neutralizing antibodiesCytokine expression patternsMultiplex reverse transcription polymerase chain reactionAnti-N protein IgGExpression of leptinDifferential cytokine expressionEnhanced antibody productionReverse transcription polymerase chain reactionVulnerability of pregnant womenCytokine array assayTranscription polymerase chain reactionCytokine profileIncidence of SARS-CoV-2 infectionImmune modulationPolymerase chain reaction
2021
Naturalization of the microbiota developmental trajectory of Cesarean-born neonates after vaginal seeding
Song SJ, Wang J, Martino C, Jiang L, Thompson WK, Shenhav L, McDonald D, Marotz C, Harris PR, Hernandez CD, Henderson N, Ackley E, Nardella D, Gillihan C, Montacuti V, Schweizer W, Jay M, Combellick J, Sun H, Garcia-Mantrana I, Gil Raga F, Collado MC, Rivera-Viñas JI, Campos-Rivera M, Ruiz-Calderon JF, Knight R, Dominguez-Bello MG. Naturalization of the microbiota developmental trajectory of Cesarean-born neonates after vaginal seeding. Med 2021, 2: 951-964.e5. PMID: 35590169, PMCID: PMC9123283, DOI: 10.1016/j.medj.2021.05.003.Peer-Reviewed Original ResearchConceptsMaternal vaginal fluidsCS birthBody sitesMaternal vaginal microbiomeVaginal fluidNon-pregnant womenDay of birthMultiple body sitesCesarean sectionImmunological underpinningsMicrobiota perturbationsClinical trialsVaginal seedingMicrobial exposureVaginal microbiomeMicrobiota developmentBabiesDisease riskBirthNational InstituteLongitudinal studyMaternal sitesPluripotential naturePublic healthFirst year
2020
Contraceptive use among women with a history of induced abortion: findings from a national sample of sexually active, non-pregnant women in Ghana
Adampah T, Angwa L, Demuyakor A, Achinkok D, Boah M. Contraceptive use among women with a history of induced abortion: findings from a national sample of sexually active, non-pregnant women in Ghana. The European Journal Of Contraception & Reproductive Health Care 2020, 25: 394-401. PMID: 32684009, DOI: 10.1080/13625187.2020.1795117.Peer-Reviewed Original ResearchConceptsHistory of induced abortionMethod of contraceptionNon-pregnant womenModern methods of contraceptionContraceptive useCurrent contraceptive usersSexually active womenSurvey logistic regression analysisReproductive-age womenExperiences of induced abortionLogistic regression analysisAssociated with modern contraceptive useStatistically significant associationContraceptive usersModern contraceptive useActive womenContraceptionSignificant associationWomenModern contraceptivesAbortionContraceptive behaviorRegression analysisHealth SurveyAnalysed data
2017
Risk Factors Associated with Persistence of Zika Virus Nucleic Acid in Serum and Semen
Lozier M, Rosenberg E, Doyle K, Adams L, Klein L, Muñoz-Jordan J, Alvarado L, Sharp T, Paz-Bailey G. Risk Factors Associated with Persistence of Zika Virus Nucleic Acid in Serum and Semen. Open Forum Infectious Diseases 2017, 4: s56-s57. PMCID: PMC5632286, DOI: 10.1093/ofid/ofx162.133.Peer-Reviewed Original ResearchDetectable ZIKV RNADays post-symptom onsetLonger median timeNon-pregnant womenZIKV RNAPregnant womenSymptom onsetMedian timeStudy participationRT-PCRPost-symptom onsetDuration of detectionRT-PCR testingZika virus RNAProportion of menVirus nucleic acidZika virus nucleic acidProspective cohortPrevention recommendationsRisk factorsIndex caseDiagnostic testingFirst monthConjunctivitisSerumImpact of pregnancy on observed sex disparities among adults hospitalized with laboratory‐confirmed influenza, FluSurv‐NET, 2010‐2012
Kline K, Hadler JL, Yousey‐Hindes K, Niccolai L, Kirley PD, Miller L, Anderson EJ, Monroe ML, Bohm SR, Lynfield R, Bargsten M, Zansky SM, Lung K, Thomas AR, Brady D, Schaffner W, Reed G, Garg S. Impact of pregnancy on observed sex disparities among adults hospitalized with laboratory‐confirmed influenza, FluSurv‐NET, 2010‐2012. Influenza And Other Respiratory Viruses 2017, 11: 404-411. PMID: 28703414, PMCID: PMC5596517, DOI: 10.1111/irv.12465.Peer-Reviewed Original ResearchConceptsIncidence rate ratiosInfluenza-associated hospitalizationsMale incidence rate ratiosPregnant womenLaboratory-confirmed influenza-associated hospitalizationsFemale incidence rate ratiosLaboratory-confirmed influenza casesLaboratory-confirmed influenzaLikelihood of vaccinationPopulation-based surveillanceNon-pregnant womenImpact of pregnancyNon-pregnant counterpartsCensus tract-level povertyObserved sex disparityGroup of womenTract-level povertyRace/ethnicityPregnant adult femalesFluSurv-NETHospitalized femalesInfluenza seasonAdult casesVaccination priorityVaccination rates
2016
Health insurance, alcohol and tobacco use among pregnant and non-pregnant women of reproductive age
Brown Q, Hasin D, Keyes K, Fink D, Ravenell O, Martins S. Health insurance, alcohol and tobacco use among pregnant and non-pregnant women of reproductive age. Drug And Alcohol Dependence 2016, 166: 116-124. PMID: 27422762, PMCID: PMC4983465, DOI: 10.1016/j.drugalcdep.2016.07.001.Peer-Reviewed Original ResearchConceptsHealth insurance coverageAssociated with lower oddsTobacco useAlcohol useInsurance coverageHealth insuranceLower oddsAssociated with tobacco useNon-pregnant womenDrug Use and Health (NSDUHPregnant womenMonth tobacco useNational Survey of Drug Use and Health (NSDUHOdds of alcohol usePregnancy statusNon-pregnant women of reproductive ageNationally Representative SampleReducing alcohol useLogistic regression modelsWomen of reproductive agePreventing tobaccoHealth carePrenatal visitMonth alcohol useMonth tobacco
2015
Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus
Rojas-Rodriguez R, Lifshitz L, Bellve K, Min S, Pires J, Leung K, Boeras C, Sert A, Draper J, Corvera S, Moore Simas T. Human adipose tissue expansion in pregnancy is impaired in gestational diabetes mellitus. Diabetologia 2015, 58: 2106-2114. PMID: 26067361, PMCID: PMC4526585, DOI: 10.1007/s00125-015-3662-0.Peer-Reviewed Original ResearchMeSH KeywordsAdipocytesAdipogenesisAdipose TissueAdiposityAdultBlood GlucoseCapillariesCross-Sectional StudiesDiabetes, GestationalFemaleGene Expression ProfilingGene Expression RegulationGlucose Tolerance TestHumansInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor IInsulin-Like Growth Factor IINeovascularization, PhysiologicOligonucleotide Array Sequence AnalysisPregnancyReal-Time Polymerase Chain ReactionConceptsGestational diabetes mellitusNormal glucose toleranceDiabetes mellitusCapillary densityAdipocyte sizeType 2 diabetes mellitusMethodsThis cross-sectional studyCapillary growthEctopic lipid depositionIGF binding proteinNon-pregnant womenCross-sectional studyAdipose tissue expansionCaesarean deliveryGlucose tolerancePregnant womenInsulin resistanceAdipocyte hypertrophyAT expansionQuantitative real-time PCRReal-time PCRIGF-1Real-time PCR studiesAims/Lipid depositionPregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men
Aliyu MH, Blevins M, Megazzini KM, Parrish DD, Audet CM, Chan N, Odoh C, Gebi UI, Muhammad MY, Shepherd BE, Wester CW, Vermund SH. Pregnant women with HIV in rural Nigeria have higher rates of antiretroviral treatment initiation, but similar loss to follow-up as non-pregnant women and men. International Health 2015, 7: 405-411. PMID: 26012740, PMCID: PMC4654753, DOI: 10.1093/inthealth/ihv032.Peer-Reviewed Original ResearchConceptsNon-pregnant womenPregnant womenPregnancy statusCumulative incidenceART-naïve patientsEarly ART initiationPost-ART initiationAntiretroviral therapy initiationDays of enrollmentART-naïve HIVAntiretroviral treatment initiationRural NigeriaART initiationHigher CD4Therapy initiationTreatment initiationClinical stageCox regressionPatient groupPregnant clientsHIVLTFUWomenHigh rateSex
2008
Epidemiological factors influencing IVF outcome: Evidence from the Yale IVF program
Matalliotakis I, Cakmak H, Arici A, Goumenou A, Fragouli Y, Sakkas D. Epidemiological factors influencing IVF outcome: Evidence from the Yale IVF program. Journal Of Obstetrics And Gynaecology 2008, 28: 204-208. PMID: 18393021, DOI: 10.1080/01443610801912436.Peer-Reviewed Original ResearchConceptsIVF outcomesFamily historyEpidemiological factorsIVF-ET cyclesIVF-ET outcomeIVF-ET treatmentNon-pregnant womenMain outcome measuresMedical School HospitalDegree of smokingAge of womenIVF-ETInfertile womenMenstrual statusObstetric historyPregnant womenRetrospective studyIVF programMedical filesFertilization outcomeMedical historyInverse associationIVF unitMenstrual symptomsOutcome measures
2007
Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia
Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. British Journal Of Cancer 2007, 96: 1480-1483. PMID: 17437020, PMCID: PMC2360194, DOI: 10.1038/sj.bjc.6603737.Peer-Reviewed Original ResearchConceptsSquamous cell carcinomaHuman papillomavirusHPV 16High-grade squamous intraepithelial lesionsDistribution of HPVHigh-risk HPV typesCervical cytological abnormalitiesTertiary care centerSquamous intraepithelial lesionsNon-pregnant womenHigh-grade lesionsHigh-risk typesSensitivity of cytologyLiquid-based cytologyHPV-52HPV typesIntraepithelial lesionsProtective immunityCell carcinomaCare centerCytological abnormalitiesHPV assessmentCell countCytologyWomen
1995
The concentration of plasma atrial natriuretic peptide in normotensive and preeclamptic pregnancies
Senöz S, Sahin N, Özcan T, Direm B, Gökmen O. The concentration of plasma atrial natriuretic peptide in normotensive and preeclamptic pregnancies. European Journal Of Obstetrics & Gynecology And Reproductive Biology 1995, 62: 173-177. PMID: 8582491, DOI: 10.1016/0301-2115(95)02191-9.Peer-Reviewed Original ResearchConceptsAtrial natriuretic peptide levelsNormotensive pregnant womenAtrial natriuretic peptideNon-pregnant womenSuperimposed preeclampsiaPregnant womenPreeclamptic womenANP levelsNatriuretic peptideConcentration of plasma atrial natriuretic peptideNormal non-pregnant womenPlasma atrial natriuretic peptidePlasma ANP levelsElevated ANP levelsPreeclamptic patientsChronic hypertensionThird trimesterVolume depletionPreeclampsiaStudy groupFamily of peptidesControl groupWomenPatientsEndocrine systemInter-individual and seasonal weight variation in rural Nepali women
Panter-Brick C. Inter-individual and seasonal weight variation in rural Nepali women. Journal Of Biosocial Science 1995, 27: 215-233. PMID: 7738083, DOI: 10.1017/s0021932000022719.Peer-Reviewed Original ResearchConceptsTotal energy expenditureBody weightMid-upper arm circumferenceHigher physical activity levelsRural Nepali womenWeight changeNon-pregnant womenBody mass indexPhysical activity levelsEnergy expenditureUpper arm circumferenceBody weight changesSeasonal weight variationInitial body weightMass indexArm circumferenceNonlactating womenFood intakePhysical activityAnthropometric measuresThin womenInter-individual variationWeight lossWomenActivity levels
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply